Nurix therapeutics announces appointment of robert tjian as chairman of scientific advisory board and his resignation from the board of directors

San francisco, oct. 26, 2020 (globe newswire) -- nurix therapeutics, inc. (nasdaq: nrix), today announced that, based on his desire to lead nurix's scientific advisory board, robert tjian, ph.d. has resigned from the company's board of directors effective november 1, 2020. dr. tjian (“tij”) has served as a member of our board of directors since november 2016. dr. tjian will continue to provide guidance and advice to nurix in his new role as chairman of nurix's scientific advisory board.
NRIX Ratings Summary
NRIX Quant Ranking